Company Filing History:

6 out of 28

Debiopharm S.a.

patents

1 out of 15

Debio Recherche Pharmaceutique S.a.

patents

3 out of 832,680

Other

patents

Years Active: 1987-2012

Loading Chart...

10 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8211940 - Oxaliplatin active substance with a very low content of oxalic acid (2012-07-03),

2. 7772184 - Use of a cyclosporin for the treatment of hepatitis C infection and pharmaceutical composition comprising said cyclosporin (2010-08-10),

3. 7439227 - Use of selected cyclosporins for the treatment of hepatitis C infection (2008-10-21),

4. 6866857 - Oxalipatinum preparation packaging (2005-03-15),

5. 6153646 - Binuclear platinum complexes, method for preparing same and (2000-11-28),

6. 5776885 - Sustained and controlled release of water insoluble polypeptides (1998-07-07),

7. 5716988 - Pharmaceutically stable preparation of oxaliplatinum (1998-02-10),

8. 5635515 - Therapeutic agents for the treatment of multiple drug resistance of (1997-06-03),

9. 5192741 - Sustained and controlled release of water insoluble polypeptides (1993-03-09),

10. 4673595 - Microencapsulation by phase separation of water-soluble medicaments (1987-06-16),

Title: Rolland-Yves Mauvernay: Innovator in Pharmaceutical Chemistry

Introduction

Rolland-Yves Mauvernay is a distinguished inventor based in Lausanne, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. His work primarily focuses on innovative solutions for medical treatments.

Latest Patents

Among his latest patents is an oxaliplatin active substance with a very low content of oxalic acid. This invention relates to a pharmaceutical composition where the weight content of oxalic acid does not exceed 0.08%. Additionally, he has developed a method for using cyclosporin in the treatment of hepatitis C infection. This invention involves a cyclosporin that has increased cyclophilin binding activity while essentially lacking immunosuppressive effects.

Career Highlights

Throughout his career, Rolland-Yves Mauvernay has worked with notable companies, including Debiopharm S.A. His innovative approaches have led to advancements in pharmaceutical formulations and treatments.

Collaborations

He has collaborated with esteemed colleagues such as Piero Orsolini and Romano Deghenghi, contributing to a rich exchange of ideas and expertise in the pharmaceutical industry.

Conclusion

Rolland-Yves Mauvernay's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact medical treatments and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.